Atlas Trials

A Bioequivalence Study of 3 Formulations of Ondansetron in Healthy Adults (0869-095)(COMPLETED)

Clinical trial NCT00971633 · COMPLETED

Trial details

NCT number
NCT00971633
Sponsor
Merck Sharp & Dohme LLC
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Chemotherapy-Induced Nausea and Vomiting
Start date
2003-11-01
Primary completion
2003-12-01
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.